Prosecution Insights
Last updated: April 19, 2026
Application No. 17/688,527

BIO-BASED EVA COMPOSITIONS AND ARTICLES AND METHODS THEREOF

Final Rejection §103
Filed
Mar 07, 2022
Examiner
RIOJA, MELISSA A
Art Unit
1764
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Braskem S A
OA Round
2 (Final)
50%
Grant Probability
Moderate
3-4
OA Rounds
3y 4m
To Grant
99%
With Interview

Examiner Intelligence

Grants 50% of resolved cases
50%
Career Allow Rate
421 granted / 847 resolved
-15.3% vs TC avg
Strong +55% interview lift
Without
With
+54.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
74 currently pending
Career history
921
Total Applications
across all art units

Statute-Specific Performance

§101
0.6%
-39.4% vs TC avg
§103
42.2%
+2.2% vs TC avg
§102
14.2%
-25.8% vs TC avg
§112
31.2%
-8.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 847 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1 – 4 are rejected under 35 U.S.C. 103 as being unpatentable over US 6,201,032 to Shyu et al. (hereinafter Shyu) in view of US 2012/0021156 to Devisme et al. (hereinafter Devisme). Regarding Claim 1. Shyu teaches a polymer composition comprising an ethylene vinyl acetate copolymer (Column 2, Lines 51 – 53). Shyu is silent with respect to bio-based carbon content of the composition and portion of ethylene in the ethylene vinyl acetate copolymer which is obtained from a renewable source of carbon. However, Devisme teaches the concept of providing a copolymer of ethylene in which the ethylene is at least partially obtained from renewable starting materials [0006]. The amount of carbon resulting from renewable starting materials may be greater than 20 weight percent and up to 100 weight percent ([0034] and [0036]), which would be reasonably expected to correspond to a bio-based content as determined by ASTM D6866-18 Method B in a substantially similar or identical numerical range. Shyu and Devisme are analogous art as they are from the same field of endeavor, namely bio-based ethylene copolymer compositions. Before the effective filing date of the instantly claimed invention, it would have been obvious to use the renewable resource-based ethylene taught by Devisme to prepare the ethylene vinyl acetate copolymer of Shyu. The motivation would have been that providing a renewable resource-based ethylene would further reduce the content of non-sustainable, petrochemical-based components in the foam of Shyu, which would further assist in the reference’s objective of reducing plastic waste (see Column 1, Lines 14 – 23). Regarding Claim 2. Shyu teaches the polymer composition of Claim 1 undergoes curing with a crosslinking agent, wherein a more preferred crosslinking agent provided therein is dicumyl peroxide (Column 2, Line 66 – Column 3, Line 11), i.e. a peroxide agent. Regarding Claim 3. Shyu teaches a foam/article prepared from the foamable polymer composition of Claim 1 (Column 2, Lines 52 – 53). The polymer composition further comprises a foaming/blowing agent and dicumyl peroxide as a more preferred crosslinking agent (Column 2, Line 53 – Column 3, Line 11), i.e. a peroxide agent. Regarding Claim 4. Shyu teaches an article prepared from the foamable polymer composition of Claim 1 (Column 2, Line 52 – Column 3, Line 17). Response to Arguments Applicant's arguments filed July 22, 2025 have been fully considered but they are not persuasive because: A) Applicant argues that there is no reasonable expectation of success in the modification of Shyu with Devisme, as neither reference teaches the use of a bio-based ethylene as a monomer in an EVA polymer. However, bio-based ethylene and petroleum-based ethylene are chemically identical (see, for example, “Bio-based Ethylene Market Growth Opportunities and Forecast by 2028 at www.theinsightpartners.com/reports/bio-based-ethylene-market). Persons of ordinary skill in the art would consequently have a reasonable expectation of success in substituting the ethylene of unknown source in Shyu with a chemically identical and sustainably sourced bio-based ethylene. B) Applicant additionally argues that the proposed combination of Shyu with Devisme would require removal of Shyu’s plant based fillers. The Office respectfully disagrees. The proposed modification suggested it would have been obvious to use the renewable resource-based ethylene taught by Devisme to prepare the ethylene vinyl acetate copolymer of Shyu. The motivation would have been that providing a renewable resource-based ethylene would further reduce the content of non-sustainable, petrochemical-based components in the foam of Shyu, which would further assist in the reference’s objective of reducing plastic waste (see Column 1, Lines 14 – 23). Thus, the outstanding rejection suggests it would have been obvious to further increase the bio-based content of the foam of Shyu beyond that initially provided by plant-based fillers of Devisme, rather than to substitute these fillers with the bio-based ethylene of Shyu. C) In response to applicant's argument that Shyu and Devisme are nonanalogous art, it has been held that a prior art reference must either be in the field of the inventor’s endeavor or, if not, then be reasonably pertinent to the particular problem with which the inventor was concerned, in order to be relied upon as a basis for rejection of the claimed invention. See In re Oetiker, 977 F.2d 1443, 24 USPQ2d 1443 (Fed. Cir. 1992). In this case, both references are in the field of the inventor’s endeavor. Though they particular source of the ethylene is not expressly disclosed by Shyu, both references are nonetheless related to ethylene copolymers. In addition, both references are reasonably pertinent to the particular problem with which the inventor was concerned, namely the development of products from renewable starting materials as replacements for conventional petrochemical based materials for the purposes of reducing negative environmental impacts. Shyu and Devisme are thus properly relied upon as a basis for rejection of the claimed invention. D) Applicant argues that the present invention achieves unexpected results, improved carbon dioxide emissions and cumulative energy demand. However, expected beneficial results are evidence of obviousness of a claimed invention, just as unexpected results are evidence of unobviousness thereof. In re Gershon, 372 F.2d 535, 538, 152 USPQ 602, 604 (CCPA 1967) The Office respectfully submits that the beneficial results observed in the instant application are reasonably considered to be expected. Persons of ordinary skill in the art would readily recognize that the use of products derived from natural sources, instead of fossil/petrochemical sources, is an effective means of reducing atmospheric carbon dioxide concentration increases, i.e. the greenhouse effect (see [0012] of US 2020/0263059). Cumulative energy demand would also be expected to be significantly lower for a natural/organic product, when compared with a petroleum-derived product (see, for example, [0155] of US 2013/0157029). Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Correspondence Any inquiry concerning this communication or earlier communications from the examiner should be directed to MELISSA RIOJA whose telephone number is (571)270-3305. The examiner can normally be reached Monday - Friday 10:00 am - 6:30 pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Arrie Lanee Reuther can be reached at (571)270-7026. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MELISSA A RIOJA/Primary Examiner, Art Unit 1764
Read full office action

Prosecution Timeline

Mar 07, 2022
Application Filed
Apr 18, 2025
Non-Final Rejection — §103
Jul 22, 2025
Response Filed
Oct 14, 2025
Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12600857
POLYETHER BLOCK AMIDE-POLY(METH)ACRYLATE FOAMS
2y 5m to grant Granted Apr 14, 2026
Patent 12599703
HYBRID HETEROGENEOUS HYDROGEL, MANUFACTURING METHOD AND USE AS AN IN-SITU NON-DEGRADABLE FILLER IMPLANT
2y 5m to grant Granted Apr 14, 2026
Patent 12584014
POROUS POLYURETHANE PARTICLE COMPOSITION AND METHODS THEREOF
2y 5m to grant Granted Mar 24, 2026
Patent 12584371
SYNTACTIC FOAM PRESSURE HOUSING
2y 5m to grant Granted Mar 24, 2026
Patent 12570786
RIGID POLYURETHANE FOAM MADE WITH A HYDROCARBON BLOWING AGENT AND 1,1,1,4,4,4-HEXAFLUOROBUT-2-ENE
2y 5m to grant Granted Mar 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
50%
Grant Probability
99%
With Interview (+54.8%)
3y 4m
Median Time to Grant
Moderate
PTA Risk
Based on 847 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month